PACE-CME

Management of hyperkalemia in CKD and HFrEF

Management of hyperkalemia in CKD and HFrEF
RestartResume

15' education - Nov. 27, 2023 - George L. Bakris, MD, David Bushinsky, MD, and Lars Lund, MD

  • Overview

    Three experts discuss the real-world evidence for the use of potassium-lowering agents in the management of hyperkalemia in patients with CKD and HFrEF. 

  • Educational information

    This video was distributed by our partner, ReachMD, a leading online learning platform for physicians and other healthcare professionals.

  • Faculty

    • George L. Bakris, MD is Professor of Medicine and Director of the ASH Comprehensive Hypertension Center at the University of Chicago Medicine in Chicago, IL, US.
    • David Bushinsky, MD is John J. Kuiper Distinguished Professor of Medicine, Emeritus Professor of Medicine and of Pharmacology and Physiology at the University of Rochester in Rochester, NY, US.
    • Lars Lund, MD is Professor of Cardiology at the Karolinska Institute and Karolinska University Hospital in Stockholm, Sweden.
  • Disclosures

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of PACE-cme.

  • Funding

    This activity is supported by an independent educational grant from CSL Vifor.

    Click here for the course on ReachMD

    The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Facebook Comments

Register

We’re glad to see you’re enjoying PACE-CME…
but how about a more personalized experience?

Register for free